Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation

HAIC Combined With Tislelizumab and Apatinib for Unresectable Intrahepatic Cholangiocarcinoma

NCT05290116 ·Status: UNKNOWN ·Phase: PHASE2

HAIC Combined with PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC

NCT03869034 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma

NCT06741020 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Efficacy and Safety of Transarterial Therapies+Donafenib + Anti-PD-1 Antibody for uHCC: A Retrospective Real-world Study

NCT05638438 ·Status: UNKNOWN

Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery

NCT04962958 ·Status: UNKNOWN ·Phase: PHASE2

Sequential T and I With H101 Via HAI for BCLC C Stage HCC: A Prospective Single-Center Single-Arm Pilot Study

NCT06685354 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Jiu-wei-zhen-xiao Granule for Advanced Hepatocellular Carcinoma

NCT03851471 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Neoadjuvant HAIC and PD-1 Plus Adjuvant PD-1 for High-risk Recurrent HCC

NCT06467799 ·Status: RECRUITING ·Phase: PHASE2

HAIC Combined With Anlotinib and TQB2450 as Adjuvant Therapy in HCC Patients With High Risk of Recurrence After Resection

NCT05311319 ·Status: UNKNOWN ·Phase: PHASE2

Radiofrequency Ablation Combined With Recombinant Human Adenovirus Type 5 in the Treatment of Hepatocellular Carcinoma.

NCT03790059 ·Status: UNKNOWN ·Phase: NA

HAIC Combined With Donafenib and Sintilimab for Unresectable ICC

NCT05348811 ·Status: COMPLETED ·Phase: PHASE2

HepaSphere Chemoembolization in Advanced HCC Patients: Safety & Efficacy Registry in China

NCT02743065 ·Status: UNKNOWN

CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection

NCT06560827 ·Status: RECRUITING ·Phase: PHASE1

HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）Plus Sintilimab and Donafenib in the First-line Treatment of Unresectable Hepatocellular Carcinoma

NCT06244225 ·Status: RECRUITING ·Phase: PHASE2

Combination Therapy of HAIC, Sintilimab and Bevacizumab for Advanced Hepatocellular Carcinoma

NCT05617430 ·Status: UNKNOWN ·Phase: PHASE2

The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma Subjects

NCT03236636 ·Status: UNKNOWN ·Phase: PHASE3

A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)

NCT00746317 ·Status: COMPLETED ·Phase: PHASE1

Yang Yin Fu Zheng Jie Du Therapy in Recurrence of Hepatocellular Carcinoma Less Than 3 cm in Diameter

NCT04264962 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Hepatic Arterial Infusion Chemotherapy in Combination With Atezolizumab and Bevacizumab for Second-line Treatment of Patients With Recurrent Liver Cancer After Liver Transplantation

NCT05833126 ·Status: RECRUITING ·Phase: PHASE2

HAIC Plus Sorafenib Versus TACE Plus Sorafenibfor Advanced HCC

NCT02856126 ·Status: COMPLETED ·Phase: PHASE3

Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial)

NCT06859684 ·Status: RECRUITING ·Phase: PHASE2

A Single-arm Clinical Study of HAIC Combined With Apatinib and Camrelizumab in the Treatment of Unresectable MTM HCC

NCT05839197 ·Status: RECRUITING ·Phase: PHASE2

A Dose Escalation Trial of Radiation Therapy (RT) for Hepatocellular Carcinoma (HCC)

NCT00960167 ·Status: UNKNOWN ·Phase: PHASE1

Antiviral Therapy for Patients With Liver Cancer After Surgery

NCT05466565 ·Status: RECRUITING

A Multicenter Study of Anlotinib in Hepatocellular Carcinoma (HCC) Patients at High Risk of Post Surgery Recurrence

NCT03945799 ·Status: TERMINATED ·Phase: PHASE1/PHASE2